Evaluation of routine health monitoring for metabolic disorders in patients with serious mental illness on psychotropic medications: a study from Ethiopia.

Autor: Zeleke TK; Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia. teryketsela2018@gmail.com., Teshome AH; Department of General Surgery, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia., Assefa MT; Department of Laboratory Science, College of Medicine and Health Sciences, Haromaya University, Harer, Ethiopia., Chanie GS; Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Abebe RB; Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Jazyk: angličtina
Zdroj: BMC psychiatry [BMC Psychiatry] 2024 Nov 12; Vol. 24 (1), pp. 795. Date of Electronic Publication: 2024 Nov 12.
DOI: 10.1186/s12888-024-06266-1
Abstrakt: Background: Compared to the overall population, patients with mental health problems are more likely to experience concurrent physical illnesses, poorer health outcomes, and mortality. Psychotropic medications, which are the pillars in the management of mental health conditions, are associated with adverse effects such as weight gain, an increased level of glucose, and elevated circulating lipid levels, all of which contribute to metabolic disorders. Inadequate health monitoring may led to suboptimal interventions and worsening of these conditions. However, there is a lack of studies assessing routine health monitoring practices for metabolic disorders and their determinants among patients with serious mental illnesses taking psychotropic medications in Ethiopia. This study aimed to evaluate routine health monitoring for metabolic disorders and its determinants in patients with serious mental illnesses on psychotropic medications in Ethiopia.
Method: A hospital based prospective follow-up study was conducted among patients with serious mental illness taking psychotropic medications who attended the outpatient psychiatry department at Debre Markos Comprehensive Specialized Hospital. Eligible participants were selected using a simple random sampling technique. Routine health monitoring was evaluated using guidelines and previous literature. Binary logistic regression was employed to identify the determinants of routine health monitoring, with statistical significance determined by a p-value of less than 0.05 and a 95% confidence interval (CI).
Results: The overall routine health monitoring practice for metabolic disorders was found to be sub-optimal. Vital signs were the most commonly assessed parameters. Key determinants of routine health monitoring included participants aged 45 and above (AOR (95% CI): 2.82 (1.34-5.92), having social insurance (AOR (95% CI): 2.94 (1.86-4.64), availability of laboratory tests at the hospital (AOR (95% CI): 3.46 (2.16-5.55), and reporting of medication-related side effects (AOR (95% CI): 1.96 (1.21-3.17)).
Conclusion: Routine health monitoring for metabolic disorders in patients with serious mental illnesses attending the outpatient psychiatry department was inadequate. Health care providers should give more attention to younger patients, those without health insurance, and who are not reported side effects. These findings provide crucial insights for improving routine health monitoring and promoting better health outcomes.
Competing Interests: Declarations Ethics approval and consent to participate This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Research and Ethics Review Committee of College of Medicine and Health Sciences at Haromaya University. All participants provided informed consent after being given comprehensive information about the study’s purpose, procedures, and confidentiality. Additionally, no identifiable personal information was included in the questionnaire to ensure respondents privacy. Clinical trial number Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje